Mothers' experiences of a lifestyle intervention for weight reduction 12 months after gestational diabetes mellitus: Qualitative findings from the PAIGE2 study

被引:3
|
作者
Kemp, Bridie J. [1 ,2 ]
Creighton, Rachel M. [1 ]
Cupples, Gina [1 ]
Kelly, Bronagh [1 ]
McAuley, Emma [1 ]
Fleck, Olwen [1 ]
Wallace, Helen [1 ]
Graham, Una [1 ]
McCance, David R. [1 ]
机构
[1] Belfast Hlth & Social Care Trust, Reg Ctr Endocrinol & Diabet, Royal Jubilee Matern Ctr, Belfast, North Ireland
[2] Queens Univ Belfast, Sch Nursing & Midwifery, Belfast, North Ireland
关键词
Gestational diabetes mellitus; Lifestyle; Overweight Obesity; Pregnancy; Type; 2; diabetes; Qualitative; Acceptability; Prevention; RETENTION; RISK;
D O I
10.1016/j.midw.2023.103911
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
The standardised pooled prevalence of gestational diabetes mellitus (GDM) globally is approximately 14 %, a reflection of increasing rates of obesity in women of childbearing age. Lifestyle interventions to reduce GDM and subsequent type 2 diabetes (T2D) have been deemed a research priority but are challenging to perform and have variable success rates. The PAIGE2 study was a pragmatic lifestyle randomised controlled trial for women with GDM and body mass index >= 25 kg/m2, which began during pregnancy and continued for one year postnatally. The primary outcome was weight loss 12 months postnatally compared with mothers receiving standard maternity care. Qualitative results are presented from end of study focus groups conducted amongst intervention mothers to gather feedback and determine acceptability of the PAIGE2 intervention. In total, 19 mothers participated in five virtual focus groups. Content analysis explored general study experience, longer term changes to lifestyle and suggested improvements of intervention components including monthly phone calls, motivational text messages, Fitbit experience, Slimming World, and study contact timings. Overall, most mothers found the individual PAIGE2 intervention components enjoyable, although opinions differed as to which were the most effective. Several mothers claimed the intervention helped them make long-term changes to their behaviours. A common suggested improvement was the establishment of a local group where mothers could share their experiences. In conclusion, most mothers deemed the intervention acceptable, and felt that with minor enhancements, it could be utilised as an effective tool to support weight loss after pregnancy and reduce future risk of obesity and T2D.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] The determinants of maintenance of body weight reduction from 12 weeks diet restriction after one year in Korean woman with Type 2 diabetes
    Ahn, Hee-Jung
    Koo, Bo-Kyung
    Jung, Ji-Yeon
    Seok, Hee-Geum
    Kim, Hyun-Jin
    Kim, Hyo-Jeong
    Park, Kang-Seo
    Han, Kyung-Ah
    Min, Kyung-Wan
    Kim, Eung-Jin
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S74 - S74
  • [42] Glycemic Control and Body Weight Reduction with Once-Weekly Semaglutide in Colombian Adults with Type 2 Diabetes: Findings from the COLIBRI Study
    Serpa-Diaz, Dagoberto
    Llanos-Florez, Carlos A.
    Uribe, Ronald Serrano
    de Salazar, Dora I. Molina
    Giraldo-Gonzalez, German C.
    Urina-Triana, Miguel
    Suarez-Rodriguez, Andres F.
    Alzate-Vinasco, Maria A.
    DIABETES THERAPY, 2024, 15 (06) : 1451 - 1460
  • [43] Obese Older Type 2 Diabetes Mellitus Patients with Muscle Insulin Resistance Benefit from an Enriched Protein Drink during Combined Lifestyle Intervention: The PROBE Study
    Pasman, Wilrike J.
    Memelink, Robert G.
    de Vogel-Van den Bosch, Johan
    Begieneman, Mark P., V
    van den Brink, Willem J.
    Weijs, Peter J. M.
    Wopereis, Suzan
    NUTRIENTS, 2020, 12 (10) : 1 - 16
  • [44] Changes in beta cell function 6 and 12 months after a diagnosis of type 1 diabetes: insights from the ADDRESS-2 study
    Sivapatham, S.
    Walkey, H. C.
    Kaur, A.
    Godsland, I. F.
    Ahmed, F.
    Busbridge, M.
    Oliver, N. S.
    Johnston, D. J.
    Misra, S.
    DIABETOLOGIA, 2019, 62 : S155 - S155
  • [45] Switching from Multiple Insulin Injections to a Fixed Combination of Degludec and Liraglutide in Patients with Type 2 Diabetes Mellitus: Results from the Simplify Study After 6 Months
    Emil Martinka
    Ingrid Dravecká
    Ivan Tkáč
    Diabetes Therapy, 2023, 14 (9) : 1503 - 1515
  • [46] Switching from Multiple Insulin Injections to a Fixed Combination of Degludec and Liraglutide in Patients with Type 2 Diabetes Mellitus: Results from the Simplify Study After 6 Months
    Martinka, Emil
    Dravecka, Ingrid
    Tkac, Ivan
    DIABETES THERAPY, 2023, 14 (09) : 1503 - 1515
  • [47] The cardio-metabolic protein profile is associated with development of type 2 diabetes at long term follow-up after gestational diabetes mellitus: Results from the OGFUS study
    Hallig, Simone J.
    Aalders, Jori
    Christensen, Maria H.
    Andersen, Marianne S.
    Vinter, Christina A.
    Dunne, Fidelma
    Hojlund, Kurt
    Jensen, Dorte M.
    Overgaard, Martin
    DIABETES OBESITY & METABOLISM, 2025, 27 (03): : 1456 - 1465
  • [48] Quercetin Intake and Absolute Telomere Length in Patients with Type 2 Diabetes Mellitus: Novel Findings from a Randomized Controlled Before-and-After Study
    Mantadaki, Aikaterini E.
    Baliou, Stella
    Linardakis, Manolis
    Vakonaki, Elena
    Tzatzarakis, Manolis N.
    Tsatsakis, Aristides
    Symvoulakis, Emmanouil K.
    PHARMACEUTICALS, 2024, 17 (09)
  • [49] Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Findings From the EXTEND-DAPT Study
    Faridi, Kamil F.
    Tamez, Hector
    Strom, Jordan B.
    Song, Yang
    Butala, Neel M.
    Shen, Changyu
    Secemsky, Eric A.
    Mauri, Laura
    Curtis, Jeptha P.
    Gibson, C. Michael
    Yeh, Robert W.
    CIRCULATION, 2020, 142 (03) : 306 - 308
  • [50] What happens after a weight loss intervention? A qualitative study of drivers and challenges of maintaining time-restricted eating among people with overweight at high risk of type 2 diabetes
    Bjerre, Natasja
    Holm, Lotte
    Veje, Nanna
    Quist, Jonas Salling
    Faerch, Kristine
    Hempler, Nana Folmann
    APPETITE, 2022, 174